Howland Capital Management LLC trimmed its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 11.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,500 shares of the company’s stock after selling 200 shares during the period. Howland Capital Management LLC’s holdings in Clorox were worth $230,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. Point72 Asset Management L.P. purchased a new position in Clorox during the fourth quarter valued at $144,844,000. Norges Bank acquired a new stake in shares of Clorox in the fourth quarter valued at about $128,382,000. Parsifal Capital Management LP acquired a new stake in shares of Clorox in the fourth quarter valued at about $128,245,000. Confluence Investment Management LLC acquired a new stake in shares of Clorox in the first quarter valued at about $135,630,000. Finally, International Assets Investment Management LLC raised its position in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after buying an additional 481,725 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Clorox Trading Up 1.3 %
Shares of CLX traded up $1.70 during trading on Friday, reaching $136.54. 46,142 shares of the company traded hands, compared to its average volume of 1,239,051. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14. The stock has a market cap of $16.96 billion, a PE ratio of 69.87, a price-to-earnings-growth ratio of 2.00 and a beta of 0.39. The stock has a 50-day simple moving average of $134.78 and a 200-day simple moving average of $143.23. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73.
Wall Street Analysts Forecast Growth
CLX has been the subject of a number of recent research reports. UBS Group reduced their target price on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Jefferies Financial Group upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price for the company in a research report on Tuesday, March 26th. Citigroup cut their price objective on shares of Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Finally, Argus upgraded shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Five analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $144.67.
View Our Latest Stock Report on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is the Dogs of the Dow Strategy? Overview and Examples
- Consumer Staple Stock’s Q2 Earnings: Key Surprises and Challenges
- What is a Special Dividend?
- 6 Best Index Mutual Funds to Invest In
- The Significance of Brokerage Rankings in Stock Selection
- Falling Inflation Sparks Optimism for These 3 Home Builder Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.